{"name":"SyneuRx International (Taiwan) Corp","slug":"syneurx-international-taiwan-corp","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi7AFBVV95cUxOa0hlZXpzZjJvWDM5QlFYd3pWOG9KTDhrM01tN2pfQnJFRUZwbmRJdm1oREk4THg0ZkpQM0F6WEdKSGJ0YWNhSVowR0tMbGhRVHBneHE1aFByTG1MN3NXVDlfWEZxbHVYXzF2R2cyaUZ2cHo1UGpYUHQ4M0VvemhtamhoZHhYVWVsVEVKZlY4NmxkTFM4dE5KdDh1MHNuN2pfQmZBVVM5SVRZNHJqNkxNR2hQWmo4STNyNTdBellaY2R3aDhlUWNfczNHWDNuWXBqNUdFOFRmb0ZxQVdyZ0pEci05QWVXR29tYzlPcA?oc=5","date":"2025-05-01","type":"pipeline","source":"PR Newswire","summary":"IGALMI Marks Significant Market Growth, Reaching New Heights in Treatment Accessibility | DelveInsight - PR Newswire","headline":"IGALMI Marks Significant Market Growth, Reaching New Heights in Treatment Accessibility | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_gFBVV95cUxNUzhJZW0zd1l4bDd5bjduazRPZUotRHhEekZ1T1RMLVljR21kaTlMVWZzdnlDam93QnVCWEZTeWFsZUZ1ZFlwX2tDNDNxZ3RUeDBuSGhmOFhBYUk2S0JRQUhQSmtGNWl5N212b0VGaWowQi1tZVlVS2UtUHhxdzhBOVZaUUhCWDNfaG9MWkpMSXpZNmM1cWFfX3ozLUxzbzdocU9kREZxWHdlQ283ZHg3dm5SeXhEcXdBVmlzSDBEemlqb3Z5RlNPNzI2RG11Rlp4SllXRHlQazgtOHRKa0xOVTJ4R3JmMEtqUlBUSFM5LUhQSzFTdnNYeTNOZEJzUQ?oc=5","date":"2025-02-21","type":"pipeline","source":"globenewswire.com","summary":"CAPLYTA’s Strong Market Adoption Propels Its Rise as a Leading Antipsychotic Therapy | DelveInsight - globenewswire.com","headline":"CAPLYTA’s Strong Market Adoption Propels Its Rise as a Leading Antipsychotic Therapy | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_gFBVV95cUxNTGJDaWxXY05HbFdIT0ZyeXhGUElYZ21PVkdaMnYtWWtQTGxSeDNJenlUc0hwNzlzQWZQVmUxaHg0S2FnN0VpRFY4MzZJa1JkbERwdVBFenM3V2NweVljcThycTFJSnBGLTU1dElueHE2alZwZ2M2cEhEcFRrbFQzdkpMTG5wS2VVTmN3Tnd1UDgyNEZkWE9QLWtJeS05dmpJeF9MR3hWMG5hRmt2aWc5Z29nWXE3Q2tzYlh5X19oLVBOTEQ2XzhfUDZ6SmZGUTNoZUR0SEdCWE1TWFFGdTgtUmc2LVFoTVJVTUIyRU5JM1pHaV9KSGN5OVcyYUg1dw?oc=5","date":"2024-08-26","type":"regulatory","source":"PR Newswire","summary":"Schizophrenia Market: RISVAN's Approval Has Sparked a Competitive Race Among Pharmaceutical Companies | DelveInsight - PR Newswire","headline":"Schizophrenia Market: RISVAN's Approval Has Sparked a Competitive Race Among Pharmaceutical Companies | DelveInsight","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMigwJBVV95cUxQa2o2MEhIdWZIWnlaVGFVSTV3ZWZ2NUZvVmFsTUd3ZW9vblNlbVVYNEJDRUYtM0NWMk45T1hqUHd4Q1RYd19aaVA2dnUwREdDSmlwS0ozcEVpMm9wZVUzdFZnd2xQWlJsMjFZMkRyV3N2M0h2bDV2TnFpZmpyVkFlSGthcF9aT2JSVk51YUJMNWcwMVV5dEkxT2NQaHhNeHFBUDVIeTk4TE1idHdzU3BOZU1pbldiLUZUVmhyZHNyOEhzZi1ZV1g5ZHh6ek1LMGtlRk5UWEwwQW9VOGtCQ0xRLUhrRENjYzFVUWZheFNUOXQxQXhaeWxZeFA4a3BUQ3kwaUhB?oc=5","date":"2023-04-05","type":"trial","source":"PR Newswire","summary":"Schizophrenia Clinical Trials Pipeline Analysis: 60+ Companies are Working to Improve the Treatment Space | DelveInsight - PR Newswire","headline":"Schizophrenia Clinical Trials Pipeline Analysis: 60+ Companies are Working to Improve the Treatment Space | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxQSmxDZ3VBSWljaV9kckg2a0FnYzhXQkZCSTN1VlNFbTRGZk1zRVRDSzY0TldHZDZvN3J2Nnc5VEF1MnBnMnBUWDhBUkVjQmZuYkpCWlZQYThPR3hJdHNldzBCQURsU3hmaHQ2enZTeDlTSzJNZFN6ZnhVVFowU0ZsVTdOWUlIaXRUc01Wc0lPcFkwanYyXzJfbmNaZW1vUmJUSk5wYWxhcHZRYW1id1RsSk1wSm9FdWJ4Wm9pTWJrRjF5SFZDbVNzNldaVmtFd2Y0eGxVZ2ZlS1E0Z1QyLXFmWg?oc=5","date":"2017-08-08","type":"pipeline","source":"BioSpectrum Asia","summary":"“BioTaiwan's growth is a reflection of the success of Taiwan biotech as a whole in recent years.†- BioSpectrum Asia","headline":"“BioTaiwan's growth is a reflection of the success of Taiwan biotech as a whole in recent years.â€","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}